|
1
|
Hagen EM: Acute complications of spinal
cord injuries. World J Orthop. 6:17–23. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sekhon LH and Fehlings MG: Epidemiology,
demographics, and pathophysiology of acute spinal cord injury.
Spine (Phila Pa 1976). 26:(24 Suppl). S2–S12. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Morawietz C and Moffat F: The effects of
locomotor training after incomplete spinal cord injury: A
systematic review. Arch Phys Med Rehabil. 94:2297–2308. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bustos ML, Huleihel L, Kapetanaki MG,
Lino-Cardenas CL, Mroz L, Ellis BM, McVerry BJ, Richards TJ,
Kaminski N, Cerdenes N, et al: Aging mesenchymal stem cells fail to
protect because of impaired migration and antiinflammatory
response. Am J Respir Crit Care Med. 189:787–798. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ansboro S, Greiser U, Barry F and Murphy
M: Strategies for improvement of therapeutic cells: Implications
for tissue repair. Eur Cells Mater. 23:310–319. 2012. View Article : Google Scholar
|
|
6
|
Kean TJ, Duesler L, Young RG, Dadabayev A,
Olenyik A, Penn M, Wagner J, Fink DJ, Caplan AI and Dennis JE:
Development of a peptide-targeted, myocardial ischemia-homing,
mesenchymal stem cell. J Drug Target. 20:23–32. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Martinez AM, Goulart CO, Bdos Ramalho S,
Oliveira JT and Almeida FM: Neurotrauma and mesenchymal stem cells
treatment: From experimental studies to clinical trials. World J
Stem Cells. 6:179–194. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Patel DM, Shah J and Srivastava AS:
Therapeutic potential of mesenchymal stem cells in regenerative
medicine. Stem Cells Int. 2013:4962182013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Robert CR, Sorkin M, Garg RK and Gurtner
GC: Stem cell recruitment after injury: Lessons for regenerative
medicine. Regen Med. 7:833–850. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Novikova LN, Brohlin M, Kingham PJ,
Novikov LN and Wiberg M: Neuroprotective and growth-promoting
effects of bone marrow stromal cells after cervical spinal cord
injury in adult rats. Cytotherapy. 13:873–887. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hoffmann J, Glassford AJ, Doyle TC,
Robbins RC, Schrepfer S and Pelletier MP: Angiogenic effects
despite limited cell survival of bone marrow-derived mesenchymal
stem cells under ischemia. Thorac Cardiovasc Surg. 58:136–142.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Eliopoulos N, Zhao J, Forner K, Birman E,
Young YK and Bouchentouf M: Erythropoietin gene-enhanced marrow
mesenchymal stromal cells decrease cisplatin-induced kidney injury
and improve survival of allogeneic mice. Mol Ther. 19:2072–2083.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Xiong M, Chen S, Yu H, Liu Z, Zeng Y and
Li F: Neuroprotection of erythropoietin and methylprednisolone
against spinal cord ischemia-reperfusion injury. J Huazhong Univ
Sci Technolog Med Sci. 31:652–656. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Teixeira M, Rodrigues-Santos P, Garrido P,
Costa E, Parada B, Sereno J, Alves R, Belo L, Teixeira F,
Santos-Silva A and Reis F: Cardiac antiapoptotic and
proproliferative effect of recombinant human erythropoietin in a
moderate stage of chronic renal failure in the rat. J Pharm
Bioallied Sci. 4:76–83. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chen S, Li J, Peng H, Zhou J and Fang H:
Administration of erythropoietin exerts protective effects against
glucocorticoid-induced osteonecrosis of the femoral head in rats.
Int J Mol Med. 33:840–848. 2014.PubMed/NCBI
|
|
16
|
Liu NM, Tian J, Wang WW, Han GF, Cheng J,
Huang J and Zhang JY: Effect of erythropoietin on mesenchymal stem
cell differentiation and secretion in vitro in an acute kidney
injury microenvironment. Genet Mol Res. 12:6477–6487. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Nair AM, Tsai YT, Shah KM, Shen J, Weng H,
Zhou J, Sun X, Saxena R, Borrelli J Jr and Tang L: The effect of
erythropoietin on autologous stem cell-mediated bone regeneration.
Biomaterials. 34:7364–7371. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Onifer SM, Zhang O, Whitnel-Smith LK, Raza
K, O'Dell CR, Lyttle TS, Rabchevsky AG, Kitzman PH and Burke DA:
Horizontal ladder task-specific re-training in adult rats with
contusive thoracic spinal cord injury. Restor Neurol Neurosci.
29:275–286. 2011.PubMed/NCBI
|
|
19
|
Deng W, Bivalacqua TJ, Chattergoon NN,
Jeter JR Jr and Kadowitz PJ: Engineering ex vivo-expanded marrow
stromal cells to secrete calcitonin gene-related peptide using
adenoviral vector. Stem Cells. 22:1279–1291. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Basso DM, Beattie MS and Bresnahan JC: A
sensitive and reliable locomotor rating scale for open field
testing in rats. J Neurotrauma. 12:1–21. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Nakano N, Nakai Y, Seo TB, Homma T, Yamada
Y, Ohta M, Suzuki Y, Nakatani T, Fukushima M, Hayashibe M and Ide
C: Effects of bone marrow stromal cell transplantation through CSF
on the subacute and chronic spinal cord injury in rats. PLoS One.
8:e734942013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Caplan AI and Correa D: PDGF in bone
formation and regeneration: New insights into a novel mechanism
involving MSCs. J Orthop Res. 29:1795–1803. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Urdzíková LM, Růžička J, LaBagnara M,
Kárová K, Kubinová Š, Jiráková K, Murali R, Syková E,
Jhanwar-Uniyal M and Jendelová P: Human mesenchymal stem cells
modulate inflammatory cytokines after spinal cord injury in rat.
Int J Mol Sci. 15:11275–11293. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Xia P, Pan S, Cheng J, Yang M, Qi Z, Hou T
and Yang X: Factors affecting directional migration of bone marrow
mesenchymal stem cells to the injured spinal cord. Neural Regen
Res. 9:1688–1695. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Nakajima H, Uchida K, Guerrero AR,
Watanabe S, Sugita D, Takeura N, Yoshida A, Long G, Wright KT,
Johnson WE and Baba H: Transplantation of mesenchymal stem cells
promotes an alternative pathway of macrophage activation and
functional recovery after spinal cord injury. J Neurotrauma.
29:1614–1625. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Mothe AJ, Bozkurt G, Catapano J, Zabojova
J, Wang X, Keating A and Tator CH: Intrathecal transplantation of
stem cells by lumbar puncture for thoracic spinal cord injury in
the rat. Spinal Cord. 49:967–973. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Boido M, Garbossa D, Fontanella M, Ducati
A and Vercelli A: Mesenchymal stem cell transplantation reduces
glial cyst and improves functional outcome after spinal cord
compression. World Neurosurg. 81:183–190. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Abrams MB, Dominguez C, Pernold K, Reger
R, Wiesenfeld-Hallin Z, Olson L and Prockop D: Multipotent
mesenchymal stromal cells attenuate chronic inflammation and
injury-induced sensitivity to mechanical stimuli in experimental
spinal cord injury. Restor Neurol Neurosci. 27:307–321.
2009.PubMed/NCBI
|
|
29
|
Osaka M, Honmou O, Murakami T, Nonaka T,
Houkin K, Hamada H and Kocsis JD: Intravenous administration of
mesenchymal stem cells derived from bone marrow after contusive
spinal cord injury improves functional outcome. Brain Res.
1343:226–235. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Cho SR, Kim YR, Kang HS, Yim SH, Park CI,
Min YH, Lee BH, Shin JC and Lim JB: Functional recovery after the
transplantation of neurally differentiated mesenchymal stem cells
derived from bone barrow in a rat model of spinal cord injury. Cell
Transplant. 18:1359–1368. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhang YJ, Zhang W, Lin CG, Ding Y, Huang
SF, Wu JL, Li Y, Dong H and Zeng YS: Neurotrophin-3 gene modified
mesenchymal stem cells promote remyelination and functional
recovery in the demyelinated spinal cord of rats. J Neurol Sci.
313:64–74. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Feng Y, Wang J, Ling S, Li Z, Li M, Li Q,
Ma Z and Yu S: Differentiation of mesenchymal stem cells into
neuronal cells on fetal bovine acellular dermal matrix as a tissue
engineered nerve scaffold. Neural Regen Res. 9:1968–1978.
2014.PubMed/NCBI
|
|
33
|
Pedram MS, Dehghan MM, Soleimani M,
Sharifi D, Marjanmehr SH and Nasiri Z: Transplantation of a
combination of autologous neural differentiated and
undifferentiated mesenchymal stem cells into injured spinal cord of
rats. Spinal Cord. 48:457–463. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Canavese M and Spaccapelo R: Protective or
pathogenic effects of vascular endothelial growth factor (VEGF) as
potential biomarker in cerebral malaria. Pathog Glob Health.
108:67–75. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Patel CB, Cohen DM, Ahobila-Vajjula P,
Sundberg LM, Chacko T and Narayana PA: Effect of VEGF treatment on
the blood-spinal cord barrier permeability in experimental spinal
cord injury: Dynamic contrast-enhanced magnetic resonance imaging.
J Neurotrauma. 26:1005–1016. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wyse RD, Dunbar GL and Rossignol J: Use of
genetically modified mesenchymal stem cells to treat
neurodegenerative diseases. Int J Mol Sci. 15:1719–1745. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Chen J, Zhang C, Jiang H, Li Y, Zhang L,
Robin A, Katakowski M, Lu M and Chopp M: Atorvastatin induction of
VEGF and BDNF promotes brain plasticity after stroke in mice. J
Cereb Blood Flow Metab. 25:281–290. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Han X, Yang N, Cui Y, Xu Y, Dang G and
Song C: Simvastatin mobilizes bone marrow stromal cells migrating
to injured areas and promotes functional recovery after spinal cord
injury in the rat. Neurosci Lett. 521:136–141. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Isele NB, Lee HS, Landshamer S, Straube A,
Padovan CS, Plesnila N and Culmsee C: Bone marrow stromal cells
mediate protection through stimulation of PI3-K/Akt and MAPK
signaling in neurons. Neurochem Int. 50:243–250. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Arishima Y, Setoguchi T, Yamaura I, Yone K
and Komiya S: Preventive effect of erythropoietin on spinal cord
cell apoptosis following acute traumatic injury in rats. Spine
(Phila Pa 1976). 31:2432–2438. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Celik M, Gökmen N, Erbayraktar S,
Akhisaroglu M, Konakc S, Ulukus C, Genc S, Genc K, Sagiroglu E,
Cerami A and Brines M: Erythropoietin prevents motor neuron
apoptosis and neurologic disability in experimental spinal cord
ischemic injury. Proc Natl Acad Sci USA. 99:2258–2263. 2002.
View Article : Google Scholar : PubMed/NCBI
|
